MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)

Lobbying for OSTEAL THERAPEUTICS, INC. · Biopharmaceutical Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $30,000.00 income · posted Jan 12, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

General federal government relations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.